Abstract
A subset of anti-infective drugs are increasingly unavailable for patients in the United States due to pricing or withdrawal from the market. Timely market solutions are needed. We assert that solutions to ensure access to some essential anti-infective agents lie outside capital markets and that public-private partnerships may be the most viable solution.
Original language | English (US) |
---|---|
Article number | e0007190 |
Journal | PLoS neglected tropical diseases |
Volume | 13 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2019 |
Keywords
- Anti-Infective Agents/economics
- Communicable Diseases/drug therapy
- Drug Industry/economics
- Drugs, Generic/economics
- Humans
- Prescription Drugs/economics
- Public Sector
- United States
- United States Food and Drug Administration
PubMed: MeSH publication types
- Journal Article